China's WuXi Biologics Snaps up Second European Pharma Plant
China's WuXi Biologics Snaps up Second European Pharma Plant
GALWAY, IRELAND--December 30, 2020--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--China's pharmaceutical major WuXi Biologics has purchased another manufacturing plant in Germany from Bayer stating that it will support its global expansion network for supplying COVID-19 vaccines and other biologics.
Within this article: Details plant purchase, cost, plans, related European plant deals
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- WuXi Snaps Up Bayer's Final Drug Manufacturing Plant in Germany
- Bayer to Cut 12,000 Jobs, Germany Hit Hard
- Idaho Sees More than $1 Billion of Projects Under Construction
- China Expects $71 Million in Gene Therapy Project Kickoffs in First-Half 20...
- Third Time Proves Unlucky for Bayer's Roundup Lawsuits